Procarbazine Hydrochloride

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (proh-KAR-buh-zeen HY-droh-KLOR-ide)

This page contains brief information about procarbazine hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Matulane
FDA Approved
Yes

Use in Cancer

Procarbazine hydrochloride is approved to be used with other drugs to treat:

Procarbazine hydrochloride is also being studied in the treatment of other types of cancer.

More About Procarbazine Hydrochloride

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information for Procarbazine - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results

Clinical Trial Results: Adding Chemotherapy to Radiation Improves Survival for Some Patients With Rare Brain Cancer - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Genetic Abnormality Predicts Treatment Benefit for Patients With Rare Brain Tumor - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trials Accepting Patients

Find Clinical Trials for Procarbazine Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: August 28, 2010
  • Updated: November 30, 2012